The role of age in post-cardiac arrest therapy in an elderly patient population by Kovács, Enikő et al.
The role of age in post-cardiac arrest therapy in an
elderly patient population
E. KOVACS1, D. PILECKY2, Z. SZAKAL-TOTH3, A. FEKETE-GY}OR4,
V.A. GYARMATHY5, L. GELLER3, B. HAUSER1, J. GAL1, B. MERKELY3 and
E. ZIMA3*
1 Department of Anaesthesiology and Intensive Therapy, Semmelweis University, Budapest, Hungary
2 Klinikum Passau, Passau, Germany
3 Heart and Vascular Center, Semmelweis University, Budapest, Hungary
4 St. George’s University Hospitals NHS Foundation Trust, London, UK
5 Johns Hopkins University, Baltimore, MD, USA
Received: February 24, 2020 • Accepted: May 4, 2020
Published online: July 20, 2020
© 2020 The Author(s)
ABSTRACT
Aim: We investigated the effect of age on post-cardiac arrest treatment outcomes in an elderly population,
based on a local database and a systemic review of the literature. Methods: Data were collected retro-
spectively from medical charts and reports. Sixty-one comatose patients, cooled to 32–34 8C for 24 h, were
categorized into three groups: younger group (≤65 years), older group (66–75 years), and very old group
(>75 years). Circumstances of cardiopulmonary resuscitation (CPR), patients’ characteristics, post-resus-
citation treatment, hemodynamic monitoring, neurologic outcome and survival were compared across age
groups. Kruskal-Wallis test, Chi-square test and binary logistic regression (BLR) were applied. In addition,
a literature search of PubMed/Medline database was performed to provide a background. Results: Age was
significantly associated with having a cardiac arrest on a monitor and a history of hypertension. No as-
sociation was found between age and survival or neurologic outcome. Age did not affect hemodynamic
parameter changes during target temperature management (TTM), except mean arterial pressure (MAP).
Need of catecholamine administration was the highest among very old patients. During the literature
review, seven papers were identified. Most studies had a retrospective design and investigated interventions
and outcome, but lacked unified age categorization. All studies reported worse survival in the elderly,
although old survivors showed a favorable neurologic outcome in most of the cases. Conclusion: There is no
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evidence to support the limitation of post-cardiac arrest therapy in the aging population. Furthermore,
additional prospective studies are needed to investigate the characteristics and outcome of post-cardiac
arrest therapy in this patient group.
KEYWORDS
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monitoring
INTRODUCTION
Populations around the world are aging rapidly as life expectancy increases and fertility de-
creases. The number of people above 90 is expected to reach 30 million by 2030 [1]. In addition,
the probability of cardiac arrest increases with age [2]. These facts implicate a considerable rise
in the proportion of old and very old patients suffering from cardiac arrest and treated in the
intensive care unit (ICU) after return of spontaneous circulation (ROSC) [3, 4]. Ample evidence
points into the direction that older age is associated with worse outcomes after out-of-hospital
cardiac arrest (OHCA) [5–13]. Moreover, comorbidities, frailty, and pathophysiological changes
related to advanced age may influence the benefits and outcome of post-cardiac arrest therapy.
Post-resuscitation treatment as a link of chain-of-survival plays an important role in the
quality of patients’ management after cardiac arrest [14]. It focuses on the prevention and
therapy of post-cardiac arrest brain injury, post-cardiac arrest myocardial dysfunction,
ischemic-reperfusion syndrome, and the precipitating cause of cardiac arrest [15]. Target
temperature management (TTM) is one of the key elements in neuroprotection in comatose
patients after ROSC and the application of 32–36 8C is recommended in these cases [14].
However, current guidelines do not differentiate between the management of older and younger
patients. There are only a few studies describing the quality and outcome of cardiopulmonary
resuscitation (CPR) and post-cardiac arrest therapy in the elderly [16–22].
The aim of our study was to investigate the characteristics and outcome of post-cardiac
arrest treatment and effect of age on post-cardiac arrest treatment outcomes in an elderly
population, based on a local database and a systemic review of the literature.
MATERIALS AND METHODS
We screened 254 patients who underwent a successful CPR after OHCA or in-hospital cardiac
arrest (IHCA) and were admitted to the ICU of Semmelweis University Heart and Vascular
Center due to a suspected cardiac origin between January 2008 and January 2015. Only
comatose patients treated with a thermo-feedback cooling device who were older than 18 years
and had no end-stage illness in history were included into our analysis. Patients, whose sus-
pected cause of cardiac arrest was active bleeding, hypovoleamia or sepsis were excluded from
the investigation. Altogether 25 patients were excluded due to insufficient documentation and
lack of data. In total, 61 patients were included into our study. Medical charts were reviewed
retrospectively to obtain demographic data, previous medical history, circumstances of CPR,
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management in the first 48 h after ROSC, hemodynamic parameters (heart rate, mean arterial
pressure (MAP), cardiac index, systemic vascular resistance index and serum lactate level)
during the different phases of TTM, length of ICU stay, length of mechanical ventilation, ce-
rebral performance category (CPC) score and survival. Patients were categorized into three
groups based on their age: 1. Younger (Y) group (patients aged 65 years or younger), 2. Older
(O) group (patients between 66 and 75 years), 3. Very Old (VO) group (patients older than 75
years). As the oldest patient was 84 years old, no older age groups were created.
The Semmelweis University Regional and Institutional Committee of Science and Research
Ethics approved our study (approval Nr.: 19/2019). No informed consent was acquired ac-
cording to our national regulations due to the retrospective nature of the study.
Patient management
Standardized post-resuscitation therapy and TTM based on our institutional protocol were
initiated as soon as possible after the admission of the patients to the ICU. The goal parameters
given by European Resuscitation Council (ERC) guidelines were utilized to guide our post-
resuscitation management [14]. Beside the standard monitoring of ICU patients (oxygen
saturation, electrocardiogram, invasive arterial blood pressure, diuresis, blood gas and serum
lactate level analysis, and echocardiography), advanced hemodynamic monitoring with
PiCCO (Pulse index Contour Cardiac Output; Pulsion Medical System, Feldkirchen,
Germany) was applied, if it was available. Measurements with thermodilution were performed
every 12 h during the first 48 h after the initiation of TTM. An acute coronarography was
performed with percutaneous coronary intervention (PCI) and/or intra-aortic balloon pump
(IABP) insertion, if indicated. Catecholamines were applied in mono- or combination therapy to
support the cardiovascular system, if clinically indicated. In the cases of severe cardiac
impairment, levosimendan treatment was initiated.
Patients were cooled to 32–34 8C according to ERC guidelines [14]. TTM consisted of three
phases: induction, maintenance, and rewarming. Patients received 30 mL/kg crystalloids, and a
Blanketrol III (Cincinatti SubZero Products, Cincinatti, USA) thermo-feedback device was
used during the induction phase. The target temperature was upheld with the same device
during the maintenance phase. After 24 h, rewarming was performed passively until normo-
thermia was reached. Patients’ core temperature was measured with an esophageal thermometer.
Sedation was sustained with intravenous opioids and benzodiazepines, and intravenous muscle
relaxant was administered in the case of severe shivering during TTM.
Outcome
Primary outcomes were 30-day and 1-year survival and neurologic outcome. Neurologic
outcome was assessed with the CPC score: CPC 1 or 2 scores stand for a good and CPC 3–5 for a
bad neurologic outcome.
Secondary outcomes were hemodynamic changes and catecholamine administration during
TTM.
Statistical analysis
Demographic data (age, gender), circumstances of CPR (location, basic life support performed,
monitor used at the time of cardiac arrest, initial rhythm), past history (hypertension,
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hyperlipidemia, myocardial infarction, diabetes, stroke), cause of cardiac arrest (ST elevation
myocardial infarction, non-ST elevation myocardial infarction, other), therapeutic steps in the
first 48 h after ROSC (acute PCI, levosimendan treatment, ejection fraction at the admission of
ICU, IABP insertion, PiCCO application, catecholamine therapy, serum lactate level, MAP,
heart rate, cardiac index and systemic vascular resistance index) and length of ICU stay, length
of mechanical ventilation, and CPC score were compared between the three groups.
Categorical variables were presented as numbers and percentages. Continuous variables were
described with medians and interquartile ranges. No more than 5% of values were missing and
were replaced with median. The chi-square test was applied for categorical variables and the
Kruskal-Wallis test with Dunn’s post hoc analysis for continuous variables.
The Kaplan-Meier curve was drawn and the log-rank test was performed to present and
compare 30-day and 1-year survival between the three groups.
Binary logistic regressions (BLRs) and receiver operating characteristic (ROC) curve analyses
were conducted. CPC, 30-day survival and 1-year survival represented the dependent variable
and age constituted the independent variable. The level of significance was set at P < 0.05.
Statistical analysis was performed using SPSS v25.0 (SPSS Inc., Chicago, IL). Figures were
created using GraphPad Prism version 8.1.1. (GraphPad Software, La Jolla, CA).
Literature review
A literature research was conducted through the PubMed/Medline database in December 2019
using the keywords (“cardiopulmonary resuscitation” OR “post-resuscitation*” OR “post-car-
diac arrest*” OR “therapeutic hypothermia” OR “target temperature management”) AND
(elderly OR age*) in order to provide a background. Inclusion criteria were original, full text
articles investigating the outcome of old (age >65 years) patients suffering a successful CPR and
receiving post-cardiac arrest therapy. Articles older than five years, articles not written in En-
glish, case reports, case series, reviews, publications without full text, studies investigating
extracorporeal CPR and papers not discussing the aspects of post-cardiac arrest therapy were
excluded. Titles and abstracts found during the literature search were screened to select
appropriate papers for final evaluation.
RESULTS
Patient characteristics
Table 1 shows basic characteristics of patients, circumstances of CPR, main steps in the first 48 h
of post-resuscitation therapy and neurologic outcome. Age was significantly associated with
having a cardiac arrest on a monitor and a history of hypertension, with younger patients having
a significantly lower probability of these conditions than older or very old patients (subgroup
analysis not shown). Older and very old patients spent more days at the ICU, but this difference
was only tendentious, not significant (P 5 0.081). The length of mechanical ventilation was
similar in all age groups.
No other differences were found between the age groups in the other assessed variables,
including PiCCO administration.
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Total 61 (100%) 31 (100%) 23 (100%) 7 (100%)
Age (years) 64 (56, 69) 56 (48, 62) 69 (67, 71) 79 (78, 81) <0.001
Gender (male) 42 (69%) 22 (71%) 16 (70%) 4 (57%) 0.772
Circumstances of CPR
OHCA 50 (82%) 27 (87%) 19 (83%) 4 (57%) 0.176
BLS performed 49 (80%) 23 (74%) 20 (83%) 7 (100%) 0.282
Patient on monitor at the time
of CA
8 (13%) 0 (0%) 5 (22%) 3 (43%) 0.003
Shockable initial rhythm 42 (69%) 23 (74%) 13 (57%) 6 (86%) 0.226
Past history
Hypertension 43 (70%) 17 (55%) 19 (83%) 7 (100%) 0.017
Hyperlipidemia 29 (48%) 11 (35%) 13 (57%) 5 (71%) 0.125
Diabetes 17 (28%) 6 (19%) 7 (30%) 4 (57%) 0.124
Myocardial infarction 15 (25%) 4 (13%) 8 (35%) 3 (43%) 0.089
Stroke 6 (10%) 2 (6%) 3 (13%) 1 (14%) 0.663
Origin of cardiac arrest
STEMI 37 (61%) 19 (61%) 16 (70%) 2 (29%) 0.150
NSTEMI 8 (13%) 3 (10%) 3 (13%) 2 (29%) 0.409
Other 16 (26%) 9 (29%) 4 (17%) 3 (42%) 0.358
Therapy in the first 48 h after ROSC
Acute PCI 49 (80%) 25 (81%) 19 (83%) 5 (71%) 0.807
Levosimendan 6 (10%) 1 (3%) 3 (13%) 2 (29%) 0.102











IABP 15 (25%) 4 (13%) 9 (39%) 2 (29%) 0.084
Length of IABP use (days) 0 (0, 0) 0 (0, 0) 0 (0, 2.5) 0 (0, 2) 0.089
PiCCO 31 (51%) 15 (48%) 12 (52%) 4 (57%) 0.904
Serum lactate 0 (mmol/L) 4.4 (3.0, 6.1) 4.4 (3.2, 5.7) 4.0 (2.2, 7.5) 5.0 (3.1, 7.8) 0.531
Serum lactate 12 (mmol/L) 2.1 (1.4, 3.2) 2.6 (1.4, 3.2) 2.1 (1.4, 4.5) 2.0 (1.4, 2.7) 0.925
Serum lactate 24 (mmol/L) 1.8 (1.2, 3.2) 1.8 (1.2, 3.2) 1.7 (1.2, 3.2) 2.6 (1.7, 3.3) 0.527
Serum lactate 48 (mmol/L) 1.7 (1.3, 2.5) 1.6 (1.2, 2.2) 2.0 (1.3, 2.5) 3.1 (1.0, 6.2) 0.326
Length of ICU stay (days) 7 (4.0, 8.0) 5.0 (3.3, 7.0) 7.0 (4.0, 10.0) 10 (5.0, 11.0) 0.081
Length of mechanical
ventilation (days)
5.0 (3.5, 7.0) 5.0 (3.0, 7.0) 6.0 (4.0, 7.0) 5.0 (5.0, 8.0) 0.220
Temperature changes in the first 48 h after ROSC
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Survival and neurologic outcome
30-day and 1-year survival (Fig. 1), as well as neurologic outcome (Table 1) were not different
across the age groups. Age was a poor predictor of 30-day survival, 1-year survival and
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Time to reach target
temperature (hours)
3.8 (2.0, 5.1) 3.0 (2.0, 5.0) 4.0 (2.0, 6.0) 3.8 (2.5, 6.0) 0.676
Outcome
CPC 1, 2 at ICU discharge 18 (30%) 8 (26%) 7 (30%) 3 (43%) 0.666
Legends: Kruskal-Wallis and Chi-square tests were applied, P < 0.05 is bolded. CPR: cardiopulmonary
resuscitation; OHCA: out-of-hospital cardiac arrest; BLS: basic life support; CA: cardiac arrest; STEMI: ST
segment elevation myocardial infarction; NSTEMI: non-ST segment elevation myocardial infarction;
ROSC: return of spontaneous circulation; PCI: percutaneous coronary intervention; ICU: intensive care
unit; IABP: intra-aortic balloon pump; PiCCO: Pulse index Contour Cardiac Output; CPC: cerebral
performance category; T: temperature.
Fig. 1. Comparison of 30-day and 1-year survival between age groups. Kaplan-Meier curves and log-rank
test were performed
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Hemodynamic management
Fig. 5 shows the comparison of heart rate, MAP and the rate of catecholamine administration
during the different phases of TTM between the groups. Very old patients had significantly
lower MAP during low temperature and after rewarming than younger patients. Additionally,
older patients had a lower MAP 24 h after the initiation of TTM than younger patients.
Furthermore, older and very old patients were more likely than younger patients to receive
catecholamines at the initiation of cooling and during low temperature.
Of those 31 patients who received PiCCO, cardiac index and systemic vascular resistance
index measured during the different phases of cooling were similar in all age categories (Fig. 6).
Fig. 2. ROC (receiver operating characteristic) curve describing the relationship between age and 30-day
survival. AUC: area under curve. Binary logistic regression (BLR) was performed. Scatter plot with median
is shown on the right with the results of Chi-square test
Fig. 3. ROC (receiver operating characteristic) curve describing the relationship between age and 1-year
survival. AUC: area under curve. Binary logistic regression (BLR) was performed. Scatter plot with median
is shown on the right with the results of Chi-square test
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Fig. 4. ROC (receiver operating characteristic) curve describing the relationship between age and neuro-
logic outcome. AUC: area under curve. CPC: cerebral performance category. Binary logistic regression
(BLR) was performed. Scatter plot with median is shown on the right with the results of Chi-square test
Fig. 5. Comparison of heart rate, mean arterial pressure and catecholamine administration during the first
48 h after ROSC between the groups. 0 h: initiation of target temperature management; 12 and 24 h: target
temperature management (32–34 8C); 48 h: measurement after rewarming. Kruskal-Wallis and Dunn’s post
hoc test were performed for continuous, and Chi-square test for categorical variables. Star: P < 0.05. Box-
and-whiskers plot are interpreted with Tukey method
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Literature review
3,419 articles were identified and screened during the literature search and finally seven were
included into the review (Fig. 7). Tables 2 and 3 summarize the characteristics and results of the
incorporated articles. Six papers applied a retrospective analysis and only one article used
Fig. 6. Comparison of cardiac index and systemic vascular resistance index during the first 48 h after ROSC
between the age groups (among the subgroup treated with PiCCO). 0 h: initiation of target temperature
management; 12 and 24 h: target temperature management (32–34 8C); 48 h: measurement after
rewarming. Kruskal-Wallis and Dunn’s post hoc test were performed
Fig. 7. Process of literature search in PubMed/Medline database
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Legends: CA: cardiac arrest; N: number of patients included into the study; TTM: target temperature management; OHCA: out-of-hospital cardiac
arrest; IHCA: in-hospital cardiac arrest; y: year; * 30-day survival; $ survival at hospital discharge; ❑ 6-month survival; & CPC1, 2 at 180 days; # CPC







Table 3. Results of the included studies
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Legends: TTM: target temperature management; CPR: cardiopulmonary resuscitation; ROSC: return of spontaneous circulation; GCS: Glasgow Coma
Scale; CCI: Charleson’s Comorbidity Index; CAG: coronary angiography; EMS: emergency medical system; y: year; NA: non-applicable (not analyzed







prospectively collected data to investigate the characteristics and outcomes of elderly patients
receiving CPR and post-cardiac arrest therapy [16–22]. Most of the studies were multicenter or
nationwide evaluations. The outcome of IHCA patients was investigated only in one paper [19].
Neither age grouping, nor the investigated outcome were unified in the studies. Additionally, the
rate of TTM was also variable among the papers. The effect of TTM on mortality of the elderly
was investigated only in one study, which could not show an association between the application
of TTM and survival [16]. Furthermore, the effect of TTM on neurologic outcome was deter-
mined in two papers: Winther-Jensen et al. reported an increase in poor neurologic outcome
with advanced age, but it was not modified by the level (33 vs. 36 8C) of TTM [22]. Walm€uller
et al. showed an association between TTM and good neurologic outcome only in patients
younger than 65 years [20]. None of the studies examined the hemodynamic effects of TTM in
the older patient group. The rate of acute PCI was analyzed in five studies: three of them showed
a decline in the number of PCIs performed with increasing age [17, 21, 22]. In addition, Aissaoui
et al. described a benefit of PCI on outcome in patients up to 75 years [16]. One article reported
the rate of administration of catecholamines: 92% of nonagenarians received catecholamine
during post-resuscitation therapy [19]. Three studies described the rate of acute therapy
termination, which was higher among older patients [19, 21, 22]. Five papers assessed the in-
dependent predictors of mortality [16–18, 20, 21], and three articles described the independent
predictors of favorable neurologic outcome [16, 18, 20] (Table 3).
All studies reported worse survival rates in older compared to younger patients. Neurologic
outcome among survivors also deteriorated with increasing age, but this decay was more
moderate and old patients survived with a favorable neurologic outcome in most of the studies.
Moreover, all the studies point out that older age should not be taken into consideration to
determine the withdrawal of intensive post-cardiac arrest therapy, since age has no significant
predictive value on mortality (Tables 2 and 3).
DISCUSSION
We aimed to give an overview of the management and outcome of elderly patients after suc-
cessful CPR and post-resuscitation therapy in our retrospective cohort study and systemic
literature review.
There are several questions, challenges and ethical dilemmas in the post-cardiac arrest
treatment of the aging population. Data from previously published studies demonstrate the
association between age and outcome in this patient group [5–13]. However, this relationship is
influenced by various factors and therefore expose many questions regarding the nature of this
finding.
We could not show any association between age, 30-day or 1-year survival and neurologic
outcome at discharge among patients treated after ROSC at our ICU. This finding fully con-
tradicts formerly published data. All papers included in our literature review found a decrease in
survival with increasing age, and four of them reported advanced age as one of the independent
predictors of mortality [16–22]. On the other hand, the association between age and neurologic
outcome was not so obvious, as four studies noticed favorable neurologic outcome among old
survivors [17, 19–21]. The rate of good neurologic outcome was the highest among very old
patients in our investigation, but this difference was not statistically significant. We would like to
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highlight that design, age categorization and measured outcomes were heterogenous in the
studies, as were the interventions during post-resuscitation therapy.
Moreover, our literature review showed that the rate of therapy termination during post-
cardiac arrest therapy was higher in the older population, nonetheless the exact conditions and
criteria of this step in the treatment were not specified. Additionally, it was previously described
that the rate of CPR initiated by the emergency medical system was lower and CPR duration was
shorter among old patients [12].
The population is aging rapidly, and life expectancy is becoming higher. In parallel, there is
an increasing number of ICU admissions of patients older than 75 years and of cardiac arrests
[23]. Furthermore, elderly people’s health conditions are better than before, as is the quality of
post-resuscitation therapy [24]. Individual patient factors, premorbid status and the circum-
stances of CPR and post-cardiac arrest therapy play an important role in the management of
elderly patients after ROSC and in the decision of therapeutic strategies.
We also evaluated the differences in post-cardiac arrest treatment between the age groups,
and found only a few dissimilarities in our retrospective analysis. The rate of acute PCI was
similar among the investigated groups. However, our literature review revealed contradicting
information, as some studies showed the same result but others found the opposite [16–18, 21,
22]. TTM was applied in all cases in our retrospective cohort. Additionally, there was no dif-
ference in TTM use among younger and older patients in the studies included into our literature
review except for two, where older patients were less likely to receive TTM [16–20, 22].
Furthermore, the question of TTM efficacy and its influence on neurologic outcome in the
elderly was raised only in two investigations with a contrary result. The post-hoc analysis of
TTM-trial showed that age had no impact on the effectiveness of TTM [22]. On the other hand,
a retrospective cohort study found a marked effect of mild therapeutic hypothermia on
neurologic outcome only among patients below 65 years [20].
The management of hemodynamic changes during post-cardiac arrest therapy and TTM
also play an important role in the post-resuscitation period. Nonetheless we found no evidence
in the literature published in the last five years assessing the hemodynamic management of the
elderly after a successful CPR. The changes in heart rate, MAP, cardiac index and systemic
vascular resistance index during TTM were described in our study. We found a significantly
lower MAP in old patients during low temperature and after rewarming, but the systemic
vascular resistance index and the cardiac index did not differ between the age groups. The
decreased MAP in the older patients may be explained by the lower vasoconstrictive response to
hypothermia in the elderly, as well as by the increased usage of antihypertensive agents due to
hypertension in this patient group. In addition, we showed an increase in catecholamine con-
sumption with increasing age. The need of catecholamines was interpreted only in one paper in
our literature review. Roedl at al. found that catecholamines were applied in 92% of patients
older than 90 years to maintain sufficient MAP during post-resuscitation therapy [19]. These
findings highlight the relevance of hemodynamic management in older patients and the
requirement of further studies focusing on this aspect.
There are several pathophysiological changes explaining the differences in hemodynamic
parameters and catecholamine consumption between the age groups. It was previously shown
that the condition of the cardiovascular system changes with age. Both experimental and clinical
studies showed that aging promotes generalized endothelial dysfunction leading to functional
alterations in the peripheral vasculature [25]. Moreover, macrovascular endothelial function
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impairment and increased endothelial stiffness were found among patients older than 65 years
[26]; however, endothelial dysfunction may be regulated with weight-loss in this patient group
[27]. NrF2 (nuclear factor-erythroid-2-related factor 2) dysfunction is one of the key elements in
promoting cell senescence leading to age-related vascular diseases [28, 29], as its impaired
function results in a lower antioxidant response [30]. Furthermore, chronically increased
sympathetic nervous system activity also plays an important role in several cardiovascular
changes in advanced age resulting hypertension, diastolic dysfunction, and increase in ven-
tricular and aortic wall thickness [31].
The long-standing shear stress during aging with or without hypertension continuously
affects vascular endothelial cell integrity and, therefore, vasodilative responsiveness. Both the
NO pathway that is responsible for vasodilation, and the alfa-adrenerg receptorial vasopressor
regulation are aggravated. Nevertheless, the latter may be the reason for higher noradrenaline
need for maintaining an optimal MAP. Our results concerning the lower blood pressure
characteristics in older patients refer to the lower vasoreactivity of the elderly under hypo-
thermic conditions, where a physiological systemic vascular resistance increase is expected.
Hypertension may also affect cerebral synapses through increased microvascular oxidative stress
and inflammation, promoting a more rapid cerebral aging [32].
There is a need for comparable, randomized controlled trials to clarify the issues raised in the
management of the elderly after CPR. Neither the data found in the literature, nor the results of
our retrospective analysis support the withholding of CPR and post-resuscitation therapy based
on age only.
Limitations
Our retrospective analysis has several restrictions, the majority of which are related to its
retrospective manner and the small size of the investigated population.
The limitations of our literature review are associated with the design and methodology of
data collection of the original papers included. Most of them performed a retrospective analysis
based on a nation-wide registry. There were no unified age classifications, investigated treatment
options and outcomes. We only included articles published in the last five years, but not earlier.
The reason for doing so was the improvement of and the dynamic changes in the assessment of
post-cardiac arrest patients during the past decade.
Despite these limitations our study gives a broad overview of all currently available data
regarding the management of elderly post-cardiac arrest patients.
Conflict of interest: The authors declare no conflict of interest.
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